Connect with us

Health

Some moms are microdosing on mushrooms, touting the benefits – but risks exist, say doctors

Published

on

Some moms are microdosing on mushrooms, touting the benefits – but risks exist, say doctors

Join Fox News for access to this content

You have reached your maximum number of articles. Log in or create an account FREE of charge to continue reading.

By entering your email and pushing continue, you are agreeing to Fox News’ Terms of Use and Privacy Policy, which includes our Notice of Financial Incentive.

Please enter a valid email address.

Having trouble? Click here.

Motherhood is a tough job — and now some moms are getting help from an unlikely source.

Thousands of mothers are taking microdoses of psychedelic or “magic” mushrooms — officially called psilocybin — to ease their stress and anxiety, according to some reports.

Advertisement

On an Instagram account called “Moms On Mushrooms,” which has over 30,000 followers, users claim mushrooms are improving their mental health.

MUSHROOM-INFUSED ‘MICRODOSING’ CHOCOLATE BARS ARE SENDING PEOPLE TO THE HOSPITAL, PROMPTING INVESTIGATION: FDA

Others, however, are concerned about the possible health risks and legal issues associated with these psychedelic substances.

Read on for both sides of the issue, including a doctor’s warning. 

Potential benefits

Peggy Van de Plassche, a Canada-based former business and finance executive, quit her job to focus her time and energy on the psychedelic industry.

Advertisement

Peggy Van de Plassche (left), a Canada-based former business and finance executive, quit her job to focus her time and energy on the psychedelic industry. (Peggy Van de Plassche / iStock)

Van De Plassche is a mom and founder of The Microdose Diet, a holistic program that includes alternative medicines such as psilocybin to “rewire the brain, calm the body, master emotions and raise energy to reach more success.”

She calls microdosing the new “biohack” for mothers to navigate their stress and anxiety around parenting, aging and work.

“Microdosing can help moms find calm and clarity in parenting, improve their emotional resilience, and even help manage postpartum depression,” Van de Plassche said in a statement to Fox News Digital.

PSYCHEDELIC RETREAT REPORTS 183% SPIKE IN BOOKINGS AS HEALTH EXPERTS CITE ‘DOWNSIDE’ OF UNREGULATED USE

Advertisement

There are three potential benefits of microdosing mushrooms, according to Van de Plassche, who is also the author of the book “MORE! The Microdose Diet – The 90-Day Plan for More Success, Passion, and Happiness.”

1. Enhanced emotional and mental well-being

Many women report significant improvements in their emotional and mental health when they begin microdosing psychedelics, according to Van de Plassche.

“These small, sub-hallucinogenic doses can stabilize mood and improve emotional responsiveness,” she told Fox News Digital via email.

Thousands of mothers are apparently taking microdoses of psychedelic or “magic” mushrooms — officially called psilocybin — to ease their stress and anxiety, according to some reports. (AP Photo/Richard Vogel, File)

“Research and anecdotal evidence suggest that microdosing may help diminish symptoms of depression, anxiety and PTSD, which disproportionately affect women.”

Advertisement

In theory, these substances can balance women’s emotions and make everyday challenges more manageable, claimed Van de Plassche.

One supporter calls microdosing the new “biohack” for mothers to navigate stress and anxiety.

One mother posted on Reddit last year about her positive experience with microdosing.

“No exaggeration, microdosing saved my life. I had terrible reactions to everything commonly prescribed to treat PTSD, and as a last resort I started microdosing,” she wrote.

“There was no high or buzz, I just stopped wanting to kill myself,” the individual wrote. “It’s been two years and my kids have a fully functional mom and my world has color.”

Advertisement

2. Increased creativity and problem-solving

“Women in creative fields, as well as those in more traditional sectors, find that microdosing enhances their problem-solving capabilities and creative thinking,” Van de Plassche said.

“This isn’t about generating a ‘high,’ but rather sparking a slight uplift in cognitive flexibility.”

“Microdosing can help moms find calm and clarity in parenting, improve their emotional resilience, even help manage postpartum depression,” claimed an advocate of mushrooms. (iStock)

In her view, microdosing helps women “think outside the box,” forge new connections and arrive at better solutions. 

“Whether at work or at home, women can benefit from more creativity with the help of microdosing,” she said.

Advertisement

3. Menopause relief and hormonal balance

Van de Plassche said she believes that microdosing can help women navigate the psychological and physiological symptoms of menopause, such as mood swings, insomnia and fatigue. 

“By modulating the serotonin system in the brain, microdoses of psychedelics might offer a new kind of equilibrium without the side effects associated with traditional hormone replacement therapies,” she told Fox News Digital.

FDA PANEL REJECTS MDMA-ASSISTED THERAPIES FOR PTSD DESPITE HIGH HOPES FROM VETERANS

“Microdosing holds particular appeal for women seeking gentle yet effective transformations,” she also said. 

Beyond helping to manage symptoms of aging, microdosing can help women “reclaim a sense of agency” over their minds and spirits, according to Van de Plassche.

Advertisement

What is a microdose?

Microdosing psilocybin involves “regularly taking very small, sub-perceptual doses of LSD or psilocybin,” which is the psychoactive compound found in certain mushrooms, according to Van de Plassche.

The ideal dose, frequency and type of mushroom can vary from one person to the next, she said.

Though some moms are swearing by this today, microdosing psychedelics can cause a psychotic or manic episode, especially in those with a personal or family history of schizophrenia or bipolar disorder, an expert warned. (iStock)

“I have found that 100 milligrams of psilocybin once every three days in the morning on an empty stomach is a great rule of thumb for most,” said Van de Plassche.

Potential risks of microdosing on mushrooms

Some medical professionals warn about a lack of research and safety concerns associated with mushrooms.

Advertisement

“There is not a lot of peer-reviewed research or safety data available for microdosing psychedelics, because these substances are not as well-studied as more traditional interventions,” Dr. Adam D. Scioli, chief medical officer of Caron Treatment Centers in Pennsylvania, told Fox News Digital.

“However, some of what we do know is concerning.”

“There is not a lot of peer-reviewed research or safety data available for microdosing psychedelics.”

Microdosing psychedelics can cause a psychotic or manic episode, especially in those with a personal or family history of schizophrenia or bipolar disorder, Scioli warned.

Other potential risks include paranoia, worsened depression or anxiety, and enhancement of emotions like worry, fear and guilt.

Advertisement

“Individuals microdose to manage emotions or feel better, but they should be aware that you can’t control which emotions you may experience,” Scioli added.

There is a risk that mushrooms may interact with other depression medications, which could be dangerous, even life-threatening, an expert warned. (iStock)

There is also the risk that mushrooms may interact with other depression medications, which could be dangerous or even life-threatening, the expert warned.

For some, the substance could lead to elevated blood pressure or heart rate, or an increased risk of stroke or sudden cardiac arrest.

“Individuals may also experience migraines, vomiting, nausea, loss of consciousness, body temperature dysregulation (too hot or too cold), loss of focus and/or brain fog,” Scioli added.

Advertisement

MAIL-ORDER KETAMINE INJECTIONS CAN BE ‘EXTREMELY DANGEROUS,’ WARNS DR. MARC SIEGEL

Until there is more conclusive research, Scioli believes that adults should avoid microdosing with mind-altering substances outside a clinical setting and under the supervision of a board-certified physician.

Some also warn of the psychological impact the practice could have on kids.

One Reddit user wrote, “I think parents shouldn’t be on any kind of drug (alcohol, vapes, grass, shrooms, tobacco, hard drugs…) when taking care of a child, because of how it will damage the health of the child. Kids can also tell when adults aren’t sober. It makes kids feel unsafe.”

Until there is more conclusive research, one addiction expert believes that adults should avoid microdosing with mind-altering substances outside a clinical setting under the supervision of a board-certified physician. (iStock)

Advertisement

Van de Plassche acknowledged that taking mushrooms too often or in excessive amounts can be risky — as can consuming “low-quality” varieties.

Women who are pregnant and breastfeeding should not microdose, she also advised.

“Men and women with dissociative mental health challenges, such as schizophrenia, should also refrain from using psychedelics,” Van de Plassche added.

Are mushrooms legal?

Psilocybin is classified as a Schedule I substance under the Controlled Substances Act, according to the Drug Enforcement Agency (DEA).

                   

Advertisement

That classification means the substance “has a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision,” as stated on the DEA’s website.

“Most microdosers have to opt for ‘civil disobedience’ in order to benefit from the practice.”

“Some states offer psychedelic-assisted therapy, which consists of large doses of psychedelics administered in a medical environment and combined with therapy,” Van de Plassche said.

“Patients usually have to jump through many hoops to access it, and it is very expensive — and mostly not covered by health insurance,” she added.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Advertisement

Availability of the substance varies by state, city and county.

Except for some “open-minded” doctors, Van de Plassche said most health practitioners will redirect patients toward more traditional therapies.

Psilocybin is classified as a Schedule I substance under the Controlled Substances Act, according to the Drug Enforcement Agency (DEA). (iStock)

“Microdosing is not a practice embraced by health professionals — yet,” she said. 

“Most microdosers have to opt for ‘civil disobedience’ in order to benefit from the practice.”

Advertisement

In most cases, the substances people use are not standardized or regulated, Scioli reiterated. 

“That means you really don’t know what you’re taking — and what you’re taking may be contaminated with other substances that can be extremely dangerous,” he said.

For more Health articles, visit www.foxnews/health

“There is also no way to tell if you’re taking too much of a substance. What may have little to no effect on one person may be extremely harmful to another person.”

Fox News Digital reached out to the DEA requesting additional comment.

Advertisement

Health

Experts Call It 2026’s Best Diet— ‘The Results Are Often Stunning’

Published

on

Experts Call It 2026’s Best Diet— ‘The Results Are Often Stunning’


Advertisement


Best Diet of 2026 Doubles Weight Loss, Burns Belly Fat Fast| Woman’s World




















Advertisement











Advertisement




Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Health

Deadly ‘superbug’ is spreading across US as drug resistance grows, researchers warn

Published

on

Deadly ‘superbug’ is spreading across US as drug resistance grows, researchers warn

NEWYou can now listen to Fox News articles!

A deadly, drug-resistant fungus already spreading rapidly through U.S. hospitals is becoming even more threatening worldwide, though there may be hope for new treatments, according to a new scientific review.

Candida auris (C. auris), often described as a “superbug fungus,” is spreading globally and increasingly resisting human immune systems, Hackensack Meridian Center for Discovery and Innovation (CDI) researchers said in a review published in early December.

The findings reinforce prior CDC warnings that have labeled C. auris an “urgent antimicrobial threat” — the first fungal pathogen to receive that designation — as U.S. cases have surged, particularly in hospitals and long-term care centers.

DANGEROUS SPIKE IN SUPERBUG INFECTIONS SURGES ACROSS US AS EXPERTS SHARE CAUTIONS

Advertisement

Approximately 7,000 cases were identified across dozens of U.S. states in 2025, according to the CDC, and it has reportedly been identified in at least 60 countries.

Candida auris is a drug-resistant fungus spreading in hospitals worldwide. (Nicolas Armer/Picture Alliance via Getty Images)

The review, published in Microbiology and Molecular Biology Reviews, helps explain why the pathogen is so difficult to contain and warns that outdated diagnostics and limited treatments lag behind. It was conducted by Dr. Neeraj Chauhan of the Hackensack Meridian CDI in New Jersey, Dr. Anuradha Chowdhary of the University of Delhi’s Medical Mycology Unit and Dr. Michail Lionakis, chief of the clinical mycology program at the National Institutes of Health.

Their findings stress the need to develop “novel antifungal agents with broad-spectrum activity against human fungal pathogens, to improve diagnostic tests and to develop immune- and vaccine-based adjunct modalities for the treatment of high-risk patients,” the researchers said in a statement.

GROWING ANTIBIOTIC CRISIS COULD TURN BACTERIAL INFECTIONS DEADLY, EXPERTS WARN

Advertisement

“In addition, future efforts should focus on raising awareness about fungal disease through developing better surveillance mechanisms, especially in resource-poor countries,” they added. “All these developments should help improve the outcomes and prognosis of patients afflicted by opportunistic fungal infections.”

Candida auris can survive on skin and hospital surfaces, allowing it to spread easily. (iStock)

First identified in 2009 from a patient’s ear sample in Japan, C. auris has since spread to dozens of countries, including the U.S., where outbreaks have forced some hospital intensive care units to shut down, according to the researchers.

The fungus poses the greatest risk to people who are already critically ill, particularly those on ventilators or with weakened immune systems. Once infected, about half of patients may die, according to some estimates.

FLU BY STATE: WHERE THIS SEASON’S HIGHLY CONTAGIOUS VARIANT IS SPREADING THE MOST

Advertisement

Unlike many other fungi, C. auris can survive on human skin and cling to hospital surfaces and medical equipment, allowing it to spread easily in healthcare settings.

“It is resistant to multiple antifungal drugs, and it tends to spread in hospital settings, including on equipment being used on immunocompromised and semi-immunocompromised patients, such as ventilators and catheters,” Dr. Marc Siegel, Fox News senior medical analyst and clinical professor of medicine at NYU Langone, previously told Fox News Digital.

Scientists say the unique cell wall structure of C. auris makes it harder to kill. (iStock)

It is also frequently misdiagnosed, delaying treatment and infection control measures.

Advertisement

“Unfortunately, symptoms such as fever, chills and aches may be ubiquitous, and it can be mistaken for other infections,” Siegel said.

In September, he said intense research was ongoing to develop new treatments.

Only four major classes of antifungal drugs are currently available, and C. auris has already shown resistance to many of them. While three new antifungal drugs have been approved or are in late-stage trials, researchers warn that drug development has struggled to keep pace with the fungus’s evolution.

CLICK HERE FOR MORE LIFESTYLE STORIES

Despite the sobering findings, there is still room for cautious optimism.

Advertisement

The fungus can cling to skin and hospital surfaces, aiding its spread. (iStock)

In separate research published in December, scientists at the University of Exeter in England discovered a potential weakness in C. auris while studying the fungus in a living-host model. 

The team found that, during infection, the fungus activates specific genes to scavenge iron, a nutrient it needs to survive, according to their paper, published in the Nature portfolio journal Communications Biology in December.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Because iron is essential for the pathogen, researchers believe drugs that block this process could eventually stop infections or even allow existing medications to be repurposed.

Advertisement

“We think our research may have revealed an Achilles’ heel in this lethal pathogen during active infection,” Dr. Hugh Gifford, a clinical lecturer at the University of Exeter and co-author of the study, said in a statement.

New research is underway to develop better treatments and diagnostics for C. auris. (iStock)

As researchers race to better understand the fungus, officials warn that strict infection control, rapid detection and continued investment in new treatments remain critical.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Health experts emphasize that C. auris is not a threat to healthy people.

Advertisement

Fox News Digital has reached out to the CDI researchers and additional experts for comment.

Fox News Digital’s Angelica Stabile contributed reporting.

Advertisement
Continue Reading

Health

Record-breaking flu numbers reported in New York state, sparking warnings from officials

Published

on

Record-breaking flu numbers reported in New York state, sparking warnings from officials

NEWYou can now listen to Fox News articles!

The New York State Department of Health reported a record surge in influenza activity, with 71,123 positive flu cases recorded statewide during the week ending December 20.

Advertisement

Health officials said the figure represents the highest number of flu cases ever reported in a single week since influenza became a reportable disease in New York in 2004.

State health data show the weekly total reflects a 38% increase from the previous reporting period, signaling a rapidly intensifying flu season.

There have been 189,312 reported positive flu cases so far this season, while influenza-related hospitalizations rose 63% in the most recent week.

FLU BY STATE: WHERE THIS SEASON’S HIGHLY CONTAGIOUS VARIANT IS SPREADING THE MOST

New York reported the highest weekly total of cases ever recorded since influenza became reportable in 2004. (iStock)

Advertisement

“We are seeing the highest number of flu cases ever recorded in a single week in New York state,” Health Commissioner Dr. James McDonald said in a press release.

There have been 189,312 reported flu cases so far this season, with influenza-related hospitalizations increasing 63% in the most recent week. (iStock)

Earlier this month, the department declared influenza prevalent statewide, a designation that requires unvaccinated health care workers to wear masks in patient care settings.

SURGE IN WHOOPING COUGH CASES IN SOUTHERN STATE PROMPTS HEALTH ALERTS

Health officials continue to emphasize that vaccination remains the most effective way to prevent severe illness and hospitalization from influenza.

Advertisement

CLICK HERE FOR MORE HEALTH STORIES

New Yorkers who have not yet received a seasonal flu shot are still encouraged to do so, with experts saying vaccination can offer protection even later in the season.

Health officials continue to urge New Yorkers to take preventive steps, including vaccination and staying home when sick, to limit further spread. (iStock)

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

To help limit further spread, the department advises individuals experiencing flu-like symptoms — including fever, cough, sore throat, or body aches — to stay home. State health officials also recommend frequent handwashing, using hand sanitizer, and avoiding close contact with sick individuals.

Advertisement

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

For those who become ill, officials say antiviral medications are available and are most effective when started within 48 hours of symptom onset.

Health officials also added that people at higher risk for complications should contact a health care provider promptly for evaluation and possible treatment.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

The department noted that flu activity typically peaks in January, meaning case counts could continue to climb in the weeks ahead.

Advertisement

Continue Reading
Advertisement

Trending